rift
valley
fever
viru
rvfv
belong
famili
bunyavirida
genu
phleboviru
zoonot
pathogen
transmit
mosquito
caus
agent
rift
valley
fever
rvf
rvf
character
high
rate
abort
fetal
malform
pregnant
rumin
febril
ill
adult
rumin
lethal
acut
hepat
newborn
lamb
human
patient
suffer
acut
febril
ill
occasion
complic
includ
partial
complet
blind
hemorrhag
fever
neurolog
disord
rvfv
transmit
droughtresist
egg
infect
floodwat
aed
mosquito
thu
play
role
maintain
rvfv
endem
area
mosquito
speci
also
involv
rvfv
transmiss
rvfvinfect
mosquito
popul
increas
subsequ
heavi
rain
fall
increas
mosquito
habitat
rvf
endem
subsaharan
africa
spread
madagascar
comoro
egypt
saudi
arabia
yemen
develop
effect
vaccin
rvf
import
nonendem
countri
prevent
spread
rvfv
rvfv
classifi
niaid
categori
prioriti
pathogen
overlap
select
agent
us
depart
health
human
servic
hh
agricultur
usda
rvfv
transmit
via
aerosol
handl
viru
done
biosafeti
level
bsl
laboratori
rvfv
tripartit
negativestrand
rna
genom
compos
small
medium
larg
l
segment
ssegment
encod
n
nss
gene
ambisens
manner
msegment
contain
singl
open
read
frame
orf
encod
nsm
protein
nsmgn
gn
gc
protein
differ
aug
cotransl
cleavag
lsegment
encod
rnadepend
rna
polymeras
nonstructur
protein
nss
major
virul
factor
inhibit
host
gener
transcript
inhibit
host
basal
transcript
factor
tf
iih
tfiih
one
six
gener
transcript
factor
tfiia
tfiib
tfiid
tfiie
tfiif
tfiih
compos
differ
protein
ie
xpd
xpb
cyclin
h
essenti
rna
synthesi
cellular
rna
polymeras
ii
nss
bind
sequest
tfiih
also
promot
degrad
tfiih
hand
nss
inhibit
activ
interferon
ifn
promot
interact
protein
recruit
repressor
complex
contain
histon
nss
promot
degrad
dsrnadepend
protein
kinas
pkr
smithburn
vaccin
gener
mous
brain
passag
rvfv
entebb
strain
sold
veterinari
vaccin
south
africa
kenya
zimbabw
namibia
egypt
israel
vaccin
caus
abort
pregnant
rumin
also
reassort
natur
wildtyp
wt
rvfv
due
use
outbreak
vaccin
gener
serial
plaquepassag
human
diploid
cell
presenc
chemic
mutagen
highli
immunogen
rumin
also
induc
suffici
immun
respons
human
exclud
select
agent
rule
us
handl
laboratori
vaccin
manufactur
use
certifi
cell
investig
new
drug
human
clinic
trial
known
rvfv
caus
spontan
truncat
nss
gene
passag
mammalian
vero
cell
lack
function
typei
ifn
system
aed
aegypti
larva
cell
recent
character
genet
subpopul
vaccin
lot
found
vaccin
retain
highli
stabl
attenu
mutat
lsegment
cultiv
cell
sinc
attenu
point
mutat
lsegment
potenti
revers
virul
exclud
requir
improv
veterinari
use
anoth
concern
lack
diva
differenti
infect
vaccin
anim
marker
previou
studi
found
mice
vaccin
induc
detect
antinss
antibodi
though
immunogen
nss
poor
presenc
antinss
antibodi
vaccin
group
compromis
diva
strategi
without
diva
marker
imposs
monitor
infect
anim
herd
vaccin
rumin
rvf
outbreak
studi
aim
develop
variant
encod
diva
marker
replic
effici
cell
although
recombin
lack
nss
gene
ssegment
encod
neg
diva
marker
ie
lack
antinss
antibodi
respons
replic
effici
typei
ifncompet
cell
phleboviru
genu
consist
sandfli
fever
group
includ
serolog
distinct
punta
toro
serocomplex
napl
serocomplex
icoaraci
serocomplex
frijol
serocomplex
sicilian
serocomplex
rvfv
uukuniemi
group
differ
phleboviru
nss
report
abl
interfer
host
typei
ifn
system
studi
develop
recombin
encod
nss
punta
toro
viru
adam
strain
ptv
sandfli
fever
sicilian
viru
sfsv
place
nss
note
lack
nss
serv
neg
diva
marker
identifi
anim
expos
wt
rvfv
attempt
identifi
vaccin
anim
detect
antibodi
specif
antiptv
nss
antisfsv
nss
character
function
nss
determin
immunogen
efficaci
outbr
mous
model
result
suggest
replic
effici
cell
efficaci
parent
also
induc
antibodi
crossreact
rvfv
nss
thu
altern
candid
vaccin
amplifi
cell
encod
neg
diva
marker
cell
atcc
cell
atcc
cell
atcc
mef
cell
maintain
dulbecco
modifi
minimum
essenti
medium
dmem
contain
fetal
calf
serum
fc
cell
stabli
express
rna
polymeras
maintain
memalpha
contain
fc
hygromycin
penicillin
uml
streptomycin
ad
cultur
media
vaccin
lot
kindli
provid
dr
jc
morril
univers
texa
medic
branch
utmb
amplifi
twice
cell
experi
rescu
plasmid
dna
cell
describ
previous
passag
cell
report
previous
rvfv
strain
stock
gener
one
cell
passag
origin
refer
collect
vial
serial
utmb
sendai
viru
cantel
strain
purchas
charl
river
north
franklin
ct
plasmid
encod
antiviralsens
ssegment
downstream
promot
describ
previous
cell
infect
ptv
adam
strain
sfsv
sabin
strain
provid
dr
rb
tesh
utmb
total
rna
extract
dpi
first
strand
cdna
synthes
superscript
ii
revers
transcriptas
invitrogen
nss
orf
amplifi
phusion
dna
polymeras
new
england
biolab
use
specif
primer
uniqu
incorpor
hpai
spei
restrict
site
clone
pcr
fragment
ptv
adam
sfsv
nss
clone
place
nss
design
ptnss
sfsnss
respect
similarli
flagtag
ad
cterminu
nss
result
plasmid
design
ptnssflag
sfsnssflag
respect
plasmid
encod
cat
nss
ptv
adam
sfsv
nss
without
tag
gener
design
report
assay
plasmid
kindli
provid
dr
r
lin
mcgill
univ
plasmid
kindli
provid
dr
ludwig
zmbe
pprdiiluc
plasmid
kindli
provid
dr
gale
jr
univ
washington
plasmid
purchas
promega
madison
wi
recombin
encod
nss
truncat
mutat
recov
use
plasmid
combin
pcaggsvg
either
ptnss
sfsnss
cell
transfect
plasmid
describ
previous
recombin
encod
nss
ptv
adam
sfsv
design
respect
recov
recombin
amplifi
cell
titrat
plaqu
assay
use
experi
addit
also
gener
recombin
encod
cterminu
flagtag
nss
ptv
adam
sfsv
mutant
design
respect
total
rna
extract
infect
mockinfect
cell
use
trizol
reagent
denatur
rna
separ
denatur
agaroseformaldehyd
gel
transfer
onto
nylon
membran
roch
appli
scienc
indianapoli
northern
blot
analysi
perform
describ
previous
strandspecif
rna
probe
detect
rvfv
antisens
ssegmentn
mrna
mous
mrna
mous
mrna
western
blot
analysi
perform
describ
previous
membran
incub
antihuman
pkr
monoclon
antibodi
bd
bioscienc
antimous
pkr
monoclon
antibodi
santa
cruz
ca
antirvfv
mous
polyclon
antibodi
kind
gift
dr
rbtesh
utmb
antiflagtag
monoclon
antibodi
sigma
goat
polyclon
antibodi
santa
cruz
ca
overnight
secondari
antibodi
santa
cruz
ca
hr
room
temperatur
cell
infect
moi
h
wash
cell
twice
media
incub
cultur
supernat
collect
remov
viral
inocula
hpi
use
plaqu
assay
viral
titer
cultur
supernat
cell
mef
cell
infect
virus
moi
collect
hpi
also
titrat
plasmid
encod
cat
linear
vitro
transcrib
use
mmessag
mmachin
ultra
kit
ambion
grand
island
ny
accord
manufactur
instruct
linear
cat
dna
contain
mychi
tag
transfect
plasmid
dna
vitro
synthes
rna
perform
use
transitmrna
transfect
kit
miru
madison
wi
accord
manufactur
instruct
respect
cell
plate
transfect
plasmid
plasmid
pprdiiluc
plasmid
addit
plasmid
hour
post
transfect
cell
mockinfect
infect
sev
uml
mocktransfect
immedi
transfect
vitro
synthes
rna
encod
cat
control
nss
ptv
adam
strain
sfsv
cell
collect
hpi
rel
luciferas
activ
measur
dualluciferas
report
assay
system
promega
madison
wi
accord
manufactur
instruct
analysi
host
gener
transcript
suppress
describ
previous
briefli
cell
mockinfect
infect
either
moi
cell
treat
mm
eu
hpi
harvest
hpi
control
transcript
suppress
cell
treat
actd
concurr
eu
treatment
incorpor
eu
detect
alexafluor
azid
invitrogen
viral
antigen
stain
antirvfv
antibodi
follow
alexafluor
secondari
antibodi
cell
analyz
flow
cytometri
lsrii
fortessa
instrument
bd
bioscienc
test
efficaci
nss
mutant
femal
outbr
mice
charl
river
north
franklin
ct
inocul
subcutan
pb
mock
n
pfu
n
n
n
n
mice
challeng
pfu
wt
rvfv
strain
ip
day
post
vaccin
challeng
experi
perform
anim
biosafeti
level
facil
utmb
shope
laboratori
mice
observ
day
challeng
bodi
weight
monitor
daili
sera
collect
day
post
vaccin
retroorbit
bleed
day
post
wt
rvfv
challeng
cardiac
punctur
surviv
curv
mice
kaplanmey
method
analyz
graphpad
prism
program
graphpad
softwar
inc
la
jolla
ca
determin
describ
previous
briefli
mous
sera
serial
dilut
transfer
flatbottom
plate
contain
viru
pfuwel
final
dilut
sera
incub
hour
dmem
fb
ad
well
mixtur
transfer
plate
confluent
cell
plate
incub
hour
remov
inocula
viru
titer
determin
plaqu
assay
eighti
averag
number
plaqu
differ
well
mockimmun
mice
sera
use
cutoff
number
typic
highest
dilut
sera
produc
number
plaqu
cutoff
number
design
neutral
antibodi
titer
histag
rvfv
n
protein
express
purifi
use
recombin
baculoviru
purifi
gsttag
rvfv
nss
ctermin
amino
acid
express
purifi
use
e
coli
coat
onto
elisa
plate
overnight
concentr
ngwell
wash
time
pb
contain
tween
pbst
well
block
pbst
contain
skim
milk
hour
well
incub
serum
sampl
dilut
antin
igg
antinss
igg
hour
well
wash
time
pbst
react
hrpconjug
antimous
igg
santa
cruz
ca
hour
wash
pbst
time
abt
ad
well
plate
incub
room
temperatur
min
optic
densiti
od
nm
record
cutoff
valu
defin
deviat
normal
mous
serum
sampl
antin
igg
cutoff
valu
defin
deviat
normal
mous
serum
sampl
highest
dilut
sera
made
od
valu
larger
cutoff
design
antin
antibodi
titer
antinss
antibodi
level
low
od
valu
dilut
use
demonstr
presenc
antinss
antibodi
statist
analys
perform
use
graphpad
prism
program
graphpad
softwar
inc
la
jolla
ca
unpair
ttest
mannwhitney
utest
use
comparison
two
group
surviv
curv
mice
analyz
logrank
mantelcox
test
mous
studi
perform
facil
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
accord
anim
welfar
act
nih
guidelin
us
feder
law
anim
protocol
approv
univers
texa
medic
branch
utmb
institut
anim
care
use
committe
iacuc
protocol
recombin
dna
rvfv
creat
upon
approv
notif
use
institut
biosafeti
committe
utmb
wt
rvfv
strain
use
robert
e
shope
laboratori
utmb
accord
nih
guidelin
us
feder
law
studi
aim
develop
modifi
vaccin
encod
nss
deriv
serolog
distinct
phlebovirus
attempt
select
phleboviru
nss
inhibit
typei
ifn
induct
use
revers
genet
rvfv
strain
recov
recombin
encod
nss
ptv
adam
strain
sfsv
fig
cell
form
clear
plaqu
similar
form
turbid
plaqu
similar
fig
ptv
adam
strain
nss
sfsv
nss
inhibit
gene
sfsv
nss
promot
degrad
pkr
first
test
replic
capabl
virus
typei
ifn
incompet
cell
mous
embryon
fibroblast
mef
cell
fig
b
cell
infect
indic
viru
multipl
infect
moi
cultur
supernat
collect
hpi
viral
titrat
cell
replic
similar
level
replic
slightli
effici
fig
mef
cell
hpi
replic
log
respect
fig
subsequ
determin
viral
growth
kinet
cell
cell
use
cultiv
vaccin
cell
replic
effici
replic
kinet
similar
replic
effici
level
nearli
similar
fig
hpi
replic
log
respect
fig
rvfv
nss
promot
degrad
pkr
thu
inhibit
phosphoryl
promot
viral
protein
synthesi
understand
function
differ
rvfv
nss
phleboviru
nss
first
test
whether
degrad
pkr
avoid
upregul
pkr
typei
ifn
use
typei
ifnincompet
cell
cell
mockinfect
infect
moi
cell
collect
hpi
western
blot
analysi
fig
expect
cell
infect
promot
degrad
pkr
cell
infect
encod
nss
ptv
sfsv
express
abund
pkr
hpi
nss
accumul
could
detect
mous
polyclon
antibodi
ptv
sfsv
probabl
due
sensit
antibodi
detect
nss
data
shown
evalu
level
nss
accumul
nss
ptv
sfsv
fuse
flagtag
cterminu
result
virus
design
respect
control
nssflag
express
also
use
encod
nss
cterminu
flagtag
cell
mockinfect
infect
moi
collect
hpi
subject
western
blot
analysi
use
antiflag
antibodi
shown
fig
confirm
nss
ptv
adam
sfsv
express
hpi
collect
conclud
promot
degrad
pkr
found
promot
degrad
pkr
clarifi
whether
induc
host
gener
transcript
suppress
cell
mockinfect
infect
moi
nascent
rna
label
eu
uridin
analog
hpi
control
transcript
suppress
mockinfect
cell
incub
actinomycin
actd
concurr
eu
treatment
incorpor
eu
coval
link
azid
conjug
alexafluor
cell
stain
antirvfv
antibodi
detect
express
viral
protein
level
euincorpor
express
viral
protein
analyz
flow
cytometri
fig
depict
acquir
data
dot
plot
express
viral
protein
antirvfv
xaxi
incorpor
eu
rna
yaxi
quadrant
gate
set
major
mock
infect
cell
upper
left
quadrant
major
actd
treat
cell
lower
left
quadrant
major
antirvfv
posit
cell
either
right
upper
lower
quadrant
cell
infect
total
cell
antirvfv
posit
cell
show
reduc
eu
incorpor
compar
mock
infect
cell
similarli
antirvfv
posit
cell
show
reduc
eu
incorpor
cell
infect
contrast
cell
infect
antirvfv
posit
cell
still
incorpor
eu
level
mock
infect
cell
fig
depict
level
eu
incorpor
antirvfv
neg
popul
mock
actd
antirvfv
posit
popul
infect
cell
histogram
rna
fluoresc
intens
eu
incorpor
plot
xaxi
cell
count
plot
yaxi
data
suggest
abl
suppress
host
transcript
wherea
neg
effect
host
rna
synthesi
found
induc
host
gener
transcript
suppress
know
whether
inhibit
gene
upregul
typei
ifncompet
mef
cell
mockinfect
infect
moi
total
rna
extract
hpi
accumul
mous
mrna
rvfv
antiviralsens
ssegment
rna
n
mrna
analyz
northern
blot
describ
previous
cell
infect
induc
mrna
infect
induc
mrna
synthesi
fig
result
suggest
ptv
sfsv
nss
inhibit
accumul
mrna
consist
previou
studi
taken
togeth
result
suggest
inhibit
host
gener
transcript
mrna
synthesi
inhibit
mrna
synthesi
host
gener
transcript
studi
observ
use
dual
luciferas
report
assay
analyz
activ
promot
two
critic
transcript
factor
gene
upregul
ifn
regulatori
nuclear
factorkappa
b
presenc
ptv
sfsv
nss
cell
transfect
plasmid
encod
firefli
luciferas
ffluc
human
promot
plasmid
encod
ffluc
copi
promot
posit
regulatori
domain
prd
iiii
motif
bind
element
pprdiiluc
plasmid
encod
ffluc
promot
prdii
motif
element
transfect
control
plasmid
encod
renilla
luciferas
rluc
constitutivelyact
promot
cotransfect
plasmid
hour
post
transfect
cell
mockinfect
infect
uml
sendai
viru
sev
immedi
mocktransfect
transfect
vitro
synthes
rna
encod
either
chloramphenicol
acetyl
transferas
cat
control
nss
ptv
adam
strain
sfsv
cell
collect
hpi
rel
luciferas
activ
measur
defin
ffluc
activ
obtain
sevinfect
cell
transfect
pprdiiluc
ffluc
activ
mockinfect
cell
transfect
pprdiiluc
show
sevinfect
cell
respect
fig
ac
left
panel
gray
bar
hand
rluc
activ
mockinfect
cell
transfect
control
plasmid
similar
increas
compar
sevinfect
cell
transfect
fig
ac
right
panel
gray
bar
result
suggest
sev
infect
specif
induc
activ
gene
compar
cat
rna
control
fig
ac
left
panel
blue
bar
cell
transfect
nss
rna
reduc
ffluc
express
level
deriv
promot
fig
left
panel
red
bar
fig
b
left
panel
red
bar
fig
c
left
panel
red
bar
result
consist
find
rvfv
nss
inhibit
gener
transcript
factor
tfiih
induc
gener
transcript
suppress
regardless
activ
similarli
cell
transfect
nss
rna
ptv
adam
reduc
ffluc
express
level
deriv
promot
fig
left
panel
yellow
bar
fig
b
left
panel
yellow
bar
fig
c
left
panel
yellow
bar
interestingli
cell
transfect
sfsv
nss
rna
consist
increas
rluc
activ
deriv
constitutivelyact
promot
fig
right
panel
pink
bar
sfsv
nss
reduc
ffluc
express
level
deriv
promot
fig
left
panel
pink
bar
fig
b
left
panel
pink
bar
fig
c
left
panel
pink
bar
result
suggest
nss
ptv
adam
nss
inhibit
report
activ
deriv
promot
sfsv
nss
inhibit
report
activ
deriv
promot
addit
sfsv
nss
seem
increas
express
constitut
activ
gene
current
unknown
mechan
base
experi
describ
confirm
induc
host
gener
transcript
suppress
inhibit
upregul
gene
promot
pkr
degrad
inhibit
upregul
gene
induc
host
gener
transcript
suppress
pkr
degrad
next
test
efficaci
wt
rvfv
challeng
outbr
mice
also
test
previous
report
encod
mutant
nss
like
inhibit
host
gener
transcript
suppress
activ
gene
promot
degrad
pkr
fiveweekold
outbr
mice
mockvaccin
pb
n
subcutan
vaccin
pfu
n
n
n
n
use
outbr
mice
evalu
immunogen
efficaci
mice
differ
genet
background
mice
monitor
daili
intraperiton
challeng
pfu
rvfv
strain
day
post
vaccin
perform
mous
elisa
use
mous
sera
day
post
vaccin
describ
previous
day
post
vaccin
mice
vaccin
increas
level
sera
serum
detect
mice
vaccin
data
shown
low
level
viremia
pfuml
detect
mice
vaccin
day
post
vaccin
day
post
vaccin
day
post
vaccin
data
shown
one
mous
vaccin
suffer
viremia
dead
day
post
vaccin
mous
vaccin
becam
moribund
euthan
day
post
vaccin
analyz
euthan
mous
vaccin
histopatholog
found
lesion
liver
spleen
enceph
character
mild
perivascular
cuf
mononuclear
cell
neuron
necrosi
infiltr
microglia
observ
viral
n
antigen
diffus
detect
parenchym
area
neuron
hippocampu
cortex
medulla
contain
viral
antigen
fig
none
mice
vaccin
die
wt
rvfv
challeng
result
suggest
retain
neuroinvas
neurovirul
similar
parent
challeng
studi
mockvaccin
mice
die
within
day
post
infect
mice
vaccin
protect
wt
rvfv
challeng
respect
fig
surviv
curv
statist
analyz
log
rank
test
differ
surviv
curv
among
mice
immun
statist
signific
mockvaccin
mous
surviv
wt
rvfv
challeng
show
reduct
bodi
weight
fig
develop
neutral
antibodi
day
post
wt
rvfv
challeng
data
shown
drop
bodi
weight
observ
euthanasia
mockvaccin
moribund
mice
wt
rvfv
challeng
fig
among
mice
vaccin
mice
develop
neutral
antibodi
plaqu
reduct
neutral
test
titer
antin
igg
titer
day
post
vaccin
mice
surviv
wt
rvfv
challeng
fig
c
tabl
surviv
mice
show
bodi
weight
rang
observ
period
fig
hand
mice
develop
neutral
antibodi
surviv
fig
die
fig
f
wt
rvfv
challeng
among
survivor
develop
antin
igg
rais
antin
igg
mous
show
tempor
bodi
weight
reduct
day
post
challeng
fig
also
develop
neutral
antibodi
day
post
challeng
hand
show
poor
efficaci
surviv
tabl
three
surviv
mice
vaccin
develop
neutral
antibodi
antin
igg
fig
surviv
mice
develop
antin
igg
without
neutral
antibodi
fig
hand
remain
mice
die
without
presenc
neutral
antibodi
mice
develop
antin
igg
fig
j
togeth
previou
observ
effici
accumul
viral
protein
due
pkrmediat
phosphoryl
result
suggest
encod
mutant
nss
inhibit
host
gener
transcript
includ
gene
promot
pkr
degrad
immunogen
poorli
induc
neutral
antibodi
compar
vaccin
mice
vaccin
develop
antin
igg
fig
tabl
furthermor
mice
vaccin
show
significantli
higher
titer
neutral
antibodi
antin
igg
vaccin
fig
c
none
surviv
mice
vaccin
show
decreas
bodi
weight
fig
result
suggest
slightli
higher
efficaci
induc
neutral
antibodi
equival
level
induc
spite
lack
pkr
degrad
function
diva
import
vaccin
rumin
inclus
neg
diva
marker
help
detect
anim
expos
wt
rvfv
outbreak
unfortun
vaccin
diva
marker
improv
requir
effici
detect
natur
infect
anim
rvf
outbreak
determin
whether
mice
vaccin
induc
igg
reactiv
rvfv
nss
purpos
use
igg
elisa
use
cterminu
rvfv
nss
use
cterminu
nss
antigen
solubl
detect
antinss
antibodi
higher
sensit
igg
elisa
use
purifi
whole
rvfv
nss
fig
shown
fig
none
mice
vaccin
induc
detect
level
igg
crossreact
cterminu
rvfv
nss
mice
vaccin
detect
antinss
igg
igg
elisa
presenc
antirvfv
nss
antibodi
vaccin
anim
compromis
diva
strategi
detect
anim
expos
wt
rvfv
hand
induc
antirvfv
nss
antibodi
detect
igg
elisa
applic
diva
also
note
mice
vaccin
rais
antinss
igg
wt
rvfv
challeng
suggest
vaccin
confer
steril
immun
wt
rvfv
replic
vaccin
mice
liveattenu
smithburn
vaccin
gener
serial
passag
wt
rvfv
entebb
strain
mous
brain
use
endem
area
veterinari
vaccin
sinc
genet
subpopul
never
report
grobbelaar
et
al
suggest
use
smithburn
strain
endem
countri
could
result
spread
rvfv
strain
multipl
use
automat
syring
virem
uninfect
rumin
outbreak
may
result
reassort
smithburn
strain
circul
wt
rvfv
outbreak
thu
liveattenu
rvf
vaccin
contain
virul
subpopul
nonattenu
segment
use
virem
anim
vaccin
strain
gener
serial
plaqu
passag
cell
presenc
safeti
immunogen
rumin
report
exclud
hhsusda
select
agent
rule
us
vaccin
gener
master
seed
current
investig
new
drug
ind
statu
us
manufactur
use
certifi
cell
human
clinic
trial
recent
character
genet
subpopul
vaccin
lot
found
major
popul
highli
stabl
revers
parent
strain
detect
differ
viral
passag
cell
rvfv
induc
nss
gene
truncat
passag
cell
lack
intact
typei
ifn
system
genet
stabil
consist
immunogen
profil
import
factor
vaccin
develop
use
cell
may
import
factor
maintain
origin
popul
manufactur
one
studi
also
suggest
strain
unknown
passag
histori
caus
abort
teratogen
effect
lamb
use
pregnant
ewe
day
pregnanc
studi
aim
develop
encod
function
nss
gene
deriv
serolog
distinct
phlebovirus
encod
diva
marker
retain
origin
efficaci
abil
effici
replic
cell
encod
diva
marker
without
affect
abil
replic
typei
ifncompet
cell
design
encod
serolog
distinct
phleboviru
nss
ptv
nss
sfsv
nss
known
inhibit
host
effici
inhibit
host
gene
upregul
induc
replic
interestingli
replic
effici
cell
indic
consid
altern
candid
vaccin
diva
marker
produc
use
cell
variant
includ
replic
cell
requir
genet
stabil
test
typei
ifnincompet
cell
optim
vaccin
product
ptv
adam
strain
inhibit
human
gene
sfsv
nss
also
inhibit
gene
express
express
wt
rvfv
place
rvfv
nss
promot
degrad
pkr
consist
wt
rvfv
encod
sfsv
nss
inhibit
upregul
gene
promot
pkr
degrad
found
ptv
nss
also
promot
pkr
degrad
fig
furthermor
ptv
nss
inhibit
host
gener
transcript
promot
sfsv
nss
inhibit
promot
host
gener
transcript
fig
interestingli
form
clear
plaqu
indistinguish
parent
form
turbid
plaqu
similar
fig
rvfv
nss
promot
degrad
pkr
previous
found
express
dominantneg
pkr
place
nss
increas
accumul
dendrit
cell
infect
mutant
hand
immunogen
efficaci
encod
nss
mutant
inhibit
host
gener
transcript
pkr
studi
inhibit
host
gener
transcript
includ
gene
without
promot
degrad
pkr
studi
found
inhibit
host
gener
transcript
includ
gene
promot
degrad
pkr
mice
vaccin
induc
high
level
neutral
antibodi
result
suggest
host
transcript
suppress
induc
rvfv
nss
neg
affect
vaccin
efficaci
pkr
inhibit
hand
encod
ptv
nss
highli
efficaci
even
though
induc
host
gener
transcript
suppress
without
induc
pkr
degrad
might
possibl
ptv
nss
unknown
function
support
rvfv
replic
presenc
host
gener
transcript
suppress
note
sfsv
nss
possess
unknown
function
increas
host
gene
express
indic
upregul
constitut
express
report
gene
fig
gene
upregul
induc
independ
pkr
degrad
may
contribut
consist
high
level
antin
igg
vaccin
mice
studi
current
conduct
laboratori
elucid
detail
mechan
ptv
nss
sfsv
nss
host
gene
express
sfsv
ptv
caus
selflimit
febril
ill
human
signific
diseas
anim
observ
one
mous
vaccin
dead
day
post
vaccin
viral
enceph
fig
vaccinerel
viral
enceph
also
observ
mice
vaccin
parent
data
shown
observ
signific
increas
mous
death
relat
vaccin
compar
vaccin
consid
vaccin
encod
fulli
function
nss
rvfv
similar
probabl
attenu
parent
due
lack
function
promot
pkr
degrad
sinc
mous
suscept
speci
rvfv
infect
vaccin
safeti
test
rumin
nonhuman
primat
consider
vaccin
candid
summari
mutant
encod
nss
ptv
sfsv
highli
efficaci
mice
encod
diva
marker
also
replic
effici
cell
use
vaccin
manufactur
process
immunogen
safeti
profil
rumin
nonhuman
primat
need
test
develop
viru
altern
vaccin
veterinari
human
use
respect
